Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2025-05-08 | 2025-10-02 | 256917 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2019-09-26 | 2019-10-04 | 94825 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-06-09 | 2022-06-17 | 162283 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2025-10-30 | 2026-01-08 | 270660 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2024-09-05 | 2024-09-19 | 236802 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194180 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-16 | 2023-08-17 | 195072 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Actual shortage | 2025-01-30 | 2025-01-30 | 249179 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147699 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2022-08-18 | 2022-12-22 | 167237 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-20 | 2023-08-18 | 195900 |
| TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2021-11-25 | 2022-01-07 | 149937 |
| TEVA-ACEBUTOLOL | 100MG | TABLET | Resolved | 2023-04-27 | 2023-10-26 | 190764 |
| TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2023-04-27 | 2023-11-03 | 190743 |
| TEVA-ACEBUTOLOL | 100MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50023 |
| TEVA-ACEBUTOLOL | 100MG | TABLET | Resolved | 2023-06-16 | 2023-07-06 | 195237 |
| TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50029 |
| TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50026 |
| TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195142 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Resolved | 2017-11-16 | 2018-11-09 | 29444 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258417 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |
| ACT QUETIAPINE | 300MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258643 |
| ACT QUETIAPINE | 200MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258648 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |